Ftse Mib
38.655,30
1,73%
DAX
22.986,82
2,01%
S&P 500
5.638,94
2,13%
NASDAQ
17.754,09
2,61%
Bitcoin
84.429,53
0,56%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Cumberland Pharmaceutical Inc (CPIX) Cumberland Pharmaceutical Inc (CPIX) Notizie

CPIX

Cumberland Pharmaceutical (CPIX)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CPIX
DataOraFonteTitoloSimboloCompagnia
10/03/202522:01Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:CPIXCumberland Pharmaceutical Inc
10/03/202522:00Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:CPIXCumberland Pharmaceutical Inc
07/03/202523:15Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:CPIXCumberland Pharmaceutical Inc
04/03/202523:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CPIXCumberland Pharmaceutical Inc
04/03/202522:05PR Newswire (US)Cumberland Pharmaceuticals Reports 11.6% Fourth Quarter 2024 Revenue GrowthNASDAQ:CPIXCumberland Pharmaceutical Inc
25/02/202522:05PR Newswire (US)CUMBERLAND PHARMACEUTICALS TO ANNOUNCE ANNUAL 2024 FINANCIAL RESULTSNASDAQ:CPIXCumberland Pharmaceutical Inc
18/02/202513:30PR Newswire (US)VIBATIV® RECEIVES MARKETING APPROVAL IN CHINANASDAQ:CPIXCumberland Pharmaceutical Inc
14/02/202522:31Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:CPIXCumberland Pharmaceutical Inc
11/02/202522:00Edgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:CPIXCumberland Pharmaceutical Inc
04/02/202522:45AllPennyStocks.comPharma Stock Soars On Phase 2 AnnouncementNASDAQ:CPIXCumberland Pharmaceutical Inc
04/02/202513:30PR Newswire (US)Cumberland Pharmaceuticals Announces Breakthrough Results from the Phase 2 FIGHT DMD Trial in Duchenne Muscular Dystrophy Heart DiseaseNASDAQ:CPIXCumberland Pharmaceutical Inc
30/01/202522:40Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:CPIXCumberland Pharmaceutical Inc
31/12/202401:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CPIXCumberland Pharmaceutical Inc
09/12/202422:05PR Newswire (US)FDA APPROVES ACETADOTE® sNDANASDAQ:CPIXCumberland Pharmaceutical Inc
08/11/202423:04Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CPIXCumberland Pharmaceutical Inc
07/11/202422:05PR Newswire (US)Cumberland Pharmaceuticals Reports Third Quarter 2024 Financial Results and Company UpdateNASDAQ:CPIXCumberland Pharmaceutical Inc
06/11/202423:21PR Newswire (US)CUMBERLAND PHARMACEUTICALS RECEIVES FDA ORPHAN DRUG AND RARE PEDIATRIC DISEASE DESIGNATIONS FOR NEW TREATMENT OF DUCHENNE MUSCULAR DYSTROPHYNASDAQ:CPIXCumberland Pharmaceutical Inc
05/11/202422:05PR Newswire (US)New Study Compares Caldolor® (ibuprofen injection) to ketorolacNASDAQ:CPIXCumberland Pharmaceutical Inc
31/10/202421:05PR Newswire (US)CUMBERLAND PHARMACEUTICALS TO ANNOUNCE THIRD QUARTER 2024 FINANCIAL RESULTSNASDAQ:CPIXCumberland Pharmaceutical Inc
06/08/202422:05PR Newswire (US)Cumberland Pharmaceuticals Reports 16% Sequential Revenue Growth in Second Quarter 2024NASDAQ:CPIXCumberland Pharmaceutical Inc
30/07/202422:05PR Newswire (US)CUMBERLAND PHARMACEUTICALS TO ANNOUNCE SECOND QUARTER 2024 FINANCIAL RESULTSNASDAQ:CPIXCumberland Pharmaceutical Inc
07/05/202422:05PR Newswire (US)Cumberland Pharmaceuticals Reports First Quarter 2024 Financial Results & Company UpdateNASDAQ:CPIXCumberland Pharmaceutical Inc
30/04/202422:05PR Newswire (US)CUMBERLAND PHARMACEUTICALS TO ANNOUNCE FIRST QUARTER 2024 FINANCIAL RESULTSNASDAQ:CPIXCumberland Pharmaceutical Inc
02/04/202422:05PR Newswire (US)NEW REPORT SUPPORTS USE OF CALDOLOR® AS A STANDARD OF CARE ACROSS PATIENT POPULATIONSNASDAQ:CPIXCumberland Pharmaceutical Inc
05/03/202422:05PR Newswire (US)Cumberland Pharmaceuticals Reports Annual 2023 Financial ResultsNASDAQ:CPIXCumberland Pharmaceutical Inc
27/02/202422:05PR Newswire (US)CUMBERLAND PHARMACEUTICALS TO ANNOUNCE ANNUAL 2023 FINANCIAL RESULTSNASDAQ:CPIXCumberland Pharmaceutical Inc
09/02/202423:27Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:CPIXCumberland Pharmaceutical Inc
27/12/202306:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CPIXCumberland Pharmaceutical Inc
15/12/202322:14Edgar (US Regulatory)Form DEL AM - Delaying amendmentNASDAQ:CPIXCumberland Pharmaceutical Inc
14/12/202323:09Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:CPIXCumberland Pharmaceutical Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CPIX

La tua Cronologia

HITB
CRDTBTC
Crypto Daily Token
HITB
KINDBTC
Kind Ads Token
NASDAQ
IRDM
Iridium Communications
BOV
I1VZ34
Invesco
KUCN
MOVRETH
MOONRIVER
UNSW3
OUCHIETH
OUCHI Token
NASDAQI
DWAMLP
DWA MLP Select
HUOB
FORTHETH
Ampleforth Governance
BOV
ATMP3R
ATMA ON
NASDAQ
ABNXGXX
Ubs Ag London Branch Aut...
BOV
BLUR11
Blue Recebiveis Imobilia...
HITB
PASSETH
Blockpass
BOV
TAKP34
Takeda Pharmaceutical
COIN
BTOUSD
Bottos
NASDAQ
ABOICXX
Ubs Ag London Branch Aut...
COIN
BTAEUR
Bata
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci